Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP-N-acetylmuramoylalanine--D-glutamate ligase (MurD) is a bacterial enzyme essential for peptidoglycan biosynthesis, catalyzing the ATP-dependent addition of D-glutamic acid to UDP-N-acetylmuramoyl-L-alanine. This step is crucial for bacterial cell wall integrity. MurD is comprised of three domains and is absent in mammals, making it a promising target for antibacterial drug development. Inhibitors targeting MurD disrupt peptidoglycan synthesis, leading to bacterial cell death.
Enzyme inhibition of peptidoglycan synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-N-acetylmuramoylalanine--D-glutamate ligase (MurD).